Table 4.
Effect of the i.p administration of the purified fraction of Curcuma zedoaria on the life span of DLA tumour bearing mice.
| Treatments | No: of mice survived after tumour inoculation (days) | Mean survival time (MST) (days) | Increase in life span (%) | ||
| 15 | 25 | 35 | |||
|
| |||||
| Group 1 (DLA Control) | 6/6 | 0/6 | 0/6 | 21 ± 2.1 | — |
| Group 2 CZPF 62.5 mg/kg bw | 6/6 | 3/6 | 0/6 | 25 ± 1.7 | 19.0 |
| Group 3 CZPF 50 mg/kg bw | 6/6 | 4/6 | 0/6 | 26 ± 2.0 | 23.8 |
| Group 4 CZPF 41.6 mg/kg bw | 6/6 | 4/6 | 0/6 | 29 ± 2.3 | 38.0 |
| Group 5 CZPF 35.7 mg/kg bw | 6/6 | 5/6 | 0/6 | 30 ± 1.9 | 42.8 |
| Group 6 CYP (25 mg/kg bw) | 6/6 | 6/6 | 3/6 | 32 ± 1.5 | 52.3 |